Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 13,482 shares at $13.16 ($177K) on 2021-11-16, disclosed to the SEC on 2021-11-17.
Seasonal sale ($177k) by SVP & Chief Accounting Officer — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.16 | 6,741 | $89K | 50.0% |
| 2 | $13.16 | 6,741 | $89K | 50.0% |
| Total | $13.16 avg | 13,482 | $177K | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |